 Concert Pharmaceuticals, Inc. NASDAQ:CNCE Q1 2022 Results Conference Call May 5, 2022 8:30 AM ET Company Participants Justine Koenigsberg - Senior Vice President, Investor Relations Roger Tung - Chief Executive Officer Marc Becker - Chief Financial Officer Nancy Stuart - Chief Operating Officer Jim Cassella - Chief Development Officer Conference Call Participants Jason Butler - JMP Securities Vamil Divan - Mizuho Securities Maury Raycroft - Jefferies Les Sulewski - Truist Securities Esther Hong - Berenberg Operator Good day, and thank you for standing by. Welcome to the Concert Pharmaceuticals First Quarter 2022 Investor Update Call. 